Skip to main content

Meet Pablo Jose

Pablo Jose was referred to St. Jude after being treated in Guatemala for ALL, the most common form of childhood cancer.

 

$

monthly

USD

Processing your donation
 
 
 
St. Jude patient Pablo Jose and his parents pose while holding hands.

St. Jude patient Pablo Jose and his parents

 
 
St. Jude patient Pablo Jose with his father.

St. Jude patient Pablo Jose with his father

 

Pablo Jose's story

Pablo Jose was diagnosed with acute lymphoblastic leukemia (ALL) in 2021 at the age of 5 in his homeland of Guatemala. ALL is the most common type of childhood cancer.

 
 

Pablo Jose received treatment in Guatemala and responded to the treatment. But after 18 months, he began to experience fevers and body pains he had felt before his initial diagnosis. Tests revealed the leukemia had returned. Doctors in Guatemala referred Pablo Jose to St. Jude Children's Research Hospital in Memphis, Tennessee.

 
St. Jude patient Pablo Jose

St. Jude patient Pablo Jose

 
 
St. Jude patient Pablo Jose with his family

St. Jude patient Pablo Jose with his family

 

Pablo Jose arrived in May 2023 at St. Jude.

Families never receive a bill from St. Jude for treatment, travel, housing or food — so they can focus on helping their child live.

Pablo Jose finished treatment and returned home. His father said he’s doing well and is full of energy. He enjoys going to school, playing soccer, drawing and painting.

 
 

For me, St. Jude is another world. It is the best in every sense of the word, not only the people who work at St. Jude but the medicine they offer.

- St. Jude patient Pablo Jose's father

 
St. Jude patient Pablo Jose with his father showing off their muscles.

St. Jude patient Pablo Jose with his father

 
 
St. Jude patient Pablo is kissed on the head by his sister as they sit cross-legged on the floor.

St. Jude patient Pablo Jose and his sister

 

St. Jude won't stop until no child — anywhere — dies from cancer.

Donate Now

Sign up for Email or Text Updates

 
 

You might also be interested in ...

Close